Cannvas MedTech (CSE:MTEC), a leading digital cannabis educator and business technology company, is pleased to announce its plans to form an independent panel of esteemed and established scientific consultants from across a range of industries to provide oversight and original content to the Cannvas.Me digital cannabis education platform. Members of the newly-formed Cannabis Sciences Advisory Board are expected to be announced in early 2019.

“We are excited to bring together scientific experts from within and outside the cannabis industry to contribute their wealth of knowledge and experience in ensuring the educational content on Cannvas.Me remains relevant as it pertains to the latest in cannabis and health sciences,” said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. “As researchers continue to unravel the science of cannabis and solve new and potentially industry-disrupting mysteries surrounding the plant and its uses – such as the developing argument of classifying cannabis by terpene profiles instead of strain names – our Cannabis Sciences Advisory Board will help ensure Cannvas.Me users continue to receive up-to-date research-based information in an easy-to-learn format.”


The newly-formed Cannabis Sciences Advisory Board joins the independent Medical Advisory Board and Educational Advisory Panel already established at Cannvas.Me. The two existing boards are made up of licenced health practitioners and certified educators from Canada and the United States. The Cannabis Sciences Advisory Board will also include prominent Canadians and Americans who are among the leaders in their fields with robust backgrounds in education, health sciences, medicine and research. Members of the Board will be in constant communication with the Cannvas.Me team to offer guidance on new educational modules, oversight of and contributions to original Cannvas.Me content, and insights into health sciences, clinical trials, medical and scientific regulatory affairs, and other related topics.

“The cannabis industry is growing like a weed and a constant stream of conflicting facts and misinformation from a range of unreliable sources underscores the crucial need for scientific evidence to support the evolving narrative of this complex plant,” said Daniel Davidzon, Director of Strategy and Education, Cannvas MedTech Inc. “The addition of a Cannabis Sciences Advisory Board allows Cannvas.Me to provide its users with an accessible and elevated educational experience based on the latest meaningful and evidence-based research being done in the science community across Canada and the world.”

Operating independent of any licenced producers or clinics, Cannvas.Me works with its Medical Advisory Board and Educational Advisory Panel to provide a safe space for cannabis education with no pressure to purchase or consume. The Cannabis Sciences Advisory Board will work toward the same goal and strive to ensure all original content relating to health and cannabis sciences is delivered to users in an accurate and relevant fashion in easily-digestible educational modules.

Aiming to be the household name in cannabis education, Cannvas.Me provides free and physician-backed digital cannabis education for all audiences wishing to learn about the potential health benefits of cannabis and whether it fits their lifestyle. The educational platform features a number of innovative modules and tools making cannabis education approachable and accessible to a global audience:

  • Cannvas Academy – educational learning modules created by licensed medical practitioners and certified educators with a focus on health care, lifestyle and wellness;
  • Cannvas Strain Matcher – an interactive experience where users learn which strain is best for alleviating specific ailments;
  • Cannvas Culinary – a culinary training module with recipes, ideas and more;
  • Cannvas Health & Fitness – combining a cannabis-healthy lifestyle with training and fitness activities;
  • Cannvas Cannabis & Science – for active and potential cannabis users interested in learning more about the science of the plant and how it impacts the human endocannabinoid system.

Additionally, the company has granted incentive stock options to purchase a total of 1,500,000 common shares at an exercise price of $0.28 per share for a period of five years to certain directors and officers in accordance with the provisions of its stock option plan.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and business technology company within the health sciences space. We design and build patient-centric platforms that enable our partners to harness the power of data to truly understand their customers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

For further information: Investor Relations: Renmark Financial Communications Inc., Shushu Feng: sfeng@renmarkfinancial.com, Tel: (416) 644-2020 or (212) 812-7680, CannvasMedTech.com

Related Links

https://cannvasmedtech.com

Click here to connect with Cannvas MedTech (CSE:MTEC) for an Investor Presentation. 

Source: www.newswire.ca

BevCanna Enterprises (CSE:BEV,OTCQQ:BVNNF,FWB:7BC) CEO Marcello Leone shared how the company is scaling up its products to forge partnerships and explore opportunities across Canada, the US and Western Europe. 

“Getting your standard processing license and being fully compliant at a federal level is critical in Canada, and we were successful in getting that done. Now we’re getting ready to launch our Keef line of beverages within the next 45 days,” Leone said. 

As a young company, Leone said BevCanna has only started, but it took a four-pronged approach to make sure that it is a revenue-generating company prepared for the opening of many jurisdictions for CBD-based products.

“We are blessed that we have a beautiful infrastructure of our own, a state-of-the-art bottling facility with a capacity of almost 200 million bottles per annum and a strong balance sheet of $55 million. We are in a strong position to scale and grow this company.”

BevCanna has received a Standard Processing License from Health Canada and is now fully authorized to begin production at its full-service, high-capacity beverage manufacturing facility. The company will begin production of its white-label products, number one US cannabis beverage brand Keef and its in-house beverages through licensed Canadian retailers, positioning the company to fully capitalize on the burgeoning Canadian cannabis-infused beverage sector.

Watch the full interview with CEO Marcello Leone above.

Keep reading... Show less

BioHarvest Sciences (CSE: BHSC) will be presenting at the Benzinga Cleantech Small Cap Conference taking place on April 22, 2021. We invite our shareholders and all interested parties to explore cleantech small cap investment opportunities through two days of networking, dealmaking and discovery.

Sign up to get a free spectator pass for the event: https://www.benzinga.com/events/small-cap/clean-tech/

Keep reading... Show less

Positive distributor feedback and strong consumer interest accelerating launch with distributors

Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today that its wholly-owned subsidiary Naturo Group has successfully completed its initial shipment of TRACE plant-based products to one of Japan’s largest beverage distributors.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or the “Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced an additional refreshment of its board of directors to further strengthen its leadership in the cannabis industry.

Keep reading... Show less